Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Mar 14, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new physical activity program for cancer patients who are hospitalized for treatment. The goal is to see if this adapted program can help improve patients' physical independence and mobility during their hospital stay. Patients will undergo a health evaluation before starting the program, which will assess their physical abilities and quality of life. If they choose to participate, they will take part in daily sessions led by a trained instructor, lasting about 20 minutes each, depending on how they're feeling.
To be eligible for this study, participants must be 18 years or older, currently receiving treatment for cancer, and not have any medical issues that would prevent them from doing physical activity. They should also be expected to stay in the hospital for at least a week. This trial aims to help patients feel better and regain strength during their treatment, and it’s important for those interested to discuss any questions or concerns with their healthcare team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Man or woman aged 18 and over (no age limit)
- • Patient followed for cancer,
- • Patients with no medical contraindication to adapted physical activity (certificate)
- • Patient with a performance index status less than 4
- • Patient hospitalized in the conventional medical oncology hospitalization department of Besançon University Hospital.
- • Patient not opposed to participating in the study
- • Patient affiliated to a French social security scheme or beneficiary of such a scheme.
- • For women: menopausal for at least 24 months, surgically sterilized, or, for women of childbearing age, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, patches contraceptives)
- • Length of hospitalization estimated at at least 7 days (main objective) and with the patient's objective of returning home or to SSR in the long term
- Exclusion Criteria:
- • Patient with an absolute medical contraindication to adapted physical activity
- • Patient with inability to understand instructions and complete questionnaires.
- • Patient with a performance index status of 4
- • Patient with legal incapacity or limited legal capacity
- • Patient unlikely to cooperate in the study and/or low cooperation anticipated by the investigator
- • Patient without health insurance
- • Pregnant woman
- • Patient being in the exclusion period of another study or provided for by the "national volunteer file".
About Centre Hospitalier Universitaire De Besancon
The Centre Hospitalier Universitaire de Besançon (CHU de Besançon) is a leading academic medical center located in Besançon, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Besançon focuses on a wide range of medical disciplines, fostering collaboration between healthcare professionals and researchers to develop new therapeutic strategies and improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the institution plays a vital role in translating research findings into practical applications, ultimately enhancing the quality of care provided to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Quentin JACQUINOT, Dr
Principal Investigator
CHU Besançon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported